Search

Your search keyword '"H. Moura"' showing total 183 results

Search Constraints

Start Over You searched for: Author "H. Moura" Remove constraint Author: "H. Moura"
183 results on '"H. Moura"'

Search Results

102. A Proteomic Characterization of Bordetella pertussis Clinical Isolates Associated with a California State Pertussis Outbreak.

103. Detection of biomarkers of pathogenic Naegleria fowleri through mass spectrometry and proteomics.

104. Govinda s. Visvesvara: a tribute.

105. The Trypanosoma rangeli trypomastigote surfaceome reveals novel proteins and targets for specific diagnosis.

106. The identification and characterization of epitopes in the 30-34 kDa Trypanosoma cruzi proteins recognized by antibodies in the serum samples of chagasic patients.

107. Proteomic Analysis and Label-Free Quantification of the Large Clostridium difficile Toxins.

108. A gel-free proteomic-based method for the characterization of Bordetella pertussis clinical isolates.

109. A rapid method for capture and identification of immunogenic proteins in Bordetella pertussis enriched membranes fractions: a fast-track strategy applicable to other microorganisms.

110. A historical and proteomic analysis of botulinum neurotoxin type/G.

111. Confirmation of botulism in birds and cattle by the mouse bioassay and Endopep-MS.

112. Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry.

113. The hawk/goose story: the classical ethological experiments of Lorenz and Tinbergen, revisited.

114. Studies on botulinum neurotoxins type /C1 and mosaic/DC using Endopep-MS and proteomics.

115. Quantitative mass spectrometry for bacterial protein toxins--a sensitive, specific, high-throughput tool for detection and diagnosis.

116. End of life in the neonatal intensive care unit.

117. Taenia crassiceps cysticerci: Characterization of the 14-kDa glycoprotein with homologies to antigens from Taenia solium cysticerci.

118. Mass spectrometric analysis of multiple pertussis toxins and toxoids.

119. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies.

120. Differentiation of Streptococcus pneumoniae conjunctivitis outbreak isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

121. MALDI-TOF mass spectrometry as a tool for differentiation of invasive and noninvasive Streptococcus pyogenes isolates.

122. Prevalence of intestinal microsporidiosis in human immunodeficiency virus-infected patients with diarrhea in major United States cities.

123. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.

124. Ambient generation of fatty acid methyl ester ions from bacterial whole cells by direct analysis in real time (DART) mass spectrometry.

125. Strain and phase identification of the U.S. category B agent Coxiella burnetii by matrix assisted laser desorption/ionization time-of-flight mass spectrometry and multivariate pattern recognition.

126. The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples.

127. Population proteomics: an emerging discipline to study metapopulation ecology.

128. Survey of albumin purification methods for the analysis of albumin-organic toxicant adducts by liquid chromatography-electrospray ionization-tandem mass spectrometry.

129. Botulinum neurotoxin detection and differentiation by mass spectrometry.

130. From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry.

131. The epidemiology of intestinal microsporidiosis in patients with HIV/AIDS in Lima, Peru.

132. Public health importance of Brachiola algerae (Microsporidia)--an emerging pathogen of humans.

133. Towards a new conceptual approach to "parasitoproteomics".

134. Standardization and denoising algorithms for mass spectra to classify whole-organism bacterial specimens.

135. Identification of biomarkers of whole Coxiella burnetii phase I by MALDI-TOF mass spectrometry.

136. Purification of Enterocytozoon bieneusi spores from stool specimens by gradient and cell sorting techniques.

137. Differences between Brachiola (Nosema) algerae isolates of human and insect origin when tested using an in vitro spore germination assay and a cultured cell infection assay.

138. Isolation of a thermotolerant Paravahlkampfia sp. from lizard intestine: biology and molecular identification.

139. Analysis of four human microsporidian isolates by MALDI-TOF mass spectrometry.

140. [Occurrence of Cryptosporidium sp in fecal samples of children less than 10 years old with clinical indication of Rotavirus].

142. Disseminated microsporidiosis caused by Encephalitozoon cuniculi III (dog type) in an Italian AIDS patient: a retrospective study.

143. The human isolate of Brachiola algerae (Phylum Microspora): development in SCID mice and description of its fine structure features.

144. Genotyping Encephalitozoon cuniculi by multilocus analyses of genes with repetitive sequences.

145. Genotyping Encephalitozoon hellem isolates by analysis of the polar tube protein gene.

146. In vitro culture, ultrastructure, antigenic, and molecular characterization of Encephalitozoon cuniculi isolated from urine and sputum samples from a Spanish patient with AIDS.

147. Genotyping Encephalitozoon parasites using multilocus analyses of genes with repetitive sequences.

149. An ELISA test to detect human serum antibodies reactive with Encephalitozoon intestinalis.

150. Clinical and diagnostic aspects of intestinal microsporidiosis in HIV-infected patients with chronic diarrhea in Rio de Janeiro, Brazil.

Catalog

Books, media, physical & digital resources